Arrowstreet Capital’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.7M | Sell |
|
|||||
|
2025
Q2 | $57.9M | Sell |
|
|||||
|
2025
Q1 | $170M | Sell |
|
|||||
|
2024
Q4 | $82.9M | Buy |
|
|||||
|
2024
Q3 | $73.2M | Buy |
|
|||||
|
2024
Q2 | $48.2M | Sell |
|
|||||
|
2024
Q1 | $42.5M | Buy |
|
|||||
|
2023
Q4 | $35.8M | Sell |
|
|||||
|
2023
Q3 | $30.1M | Buy |
|
|||||
|
2023
Q2 | $6.3M | Buy |
|
|||||
|
2023
Q1 | $219K | Sell |
|
|||||
|
2022
Q4 | $468K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $318K | Sell |
|
|||||
|
2021
Q4 | $9.72M | Sell |
|
|||||
|
2021
Q3 | $29.3M | Buy |
|
|||||
|
2021
Q2 | $14M | Sell |
|
|||||
|
2021
Q1 | $24.9M | Buy |
|
|||||
|
2020
Q4 | $26.8M | Buy |
|
|||||
|
2020
Q3 | $16.4M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Sell |
|
|||||
|
2020
Q1 | $14.1M | Sell |
|
|||||
|
2019
Q4 | $17.1M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3.69M | Buy |
|
|||||
|
2018
Q4 | $2.98M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $13.4M | Buy |
|
|||||
|
2018
Q1 | $13.8M | Buy |
|
|||||
|
2017
Q4 | $9.78M | Sell |
|
|||||
|
2017
Q3 | $12M | Buy |
|
|||||
|
2017
Q2 | $1.17M | Sell |
|
|||||
|
2017
Q1 | $2.56M | Buy |
|